Tower Research Capital (TRC)’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$29.6K Buy
2025
Q1
$9.48K Buy
2024
Q4
$13.8K Buy
2024
Q3
$9.19K Buy
2024
Q2
$1.66K Buy